VERONESI, PAOLO
 Distribuzione geografica
Continente #
EU - Europa 27.912
AS - Asia 19.830
NA - Nord America 18.586
SA - Sud America 3.195
AF - Africa 635
OC - Oceania 242
Continente sconosciuto - Info sul continente non disponibili 29
Totale 70.429
Nazione #
US - Stati Uniti d'America 17.412
DE - Germania 10.125
CN - Cina 6.019
SG - Singapore 5.010
IT - Italia 4.920
GB - Regno Unito 3.802
BR - Brasile 2.104
RU - Federazione Russa 1.672
HK - Hong Kong 1.618
VN - Vietnam 1.334
SE - Svezia 1.318
FR - Francia 1.257
IN - India 1.116
ES - Italia 948
TR - Turchia 867
JP - Giappone 785
BD - Bangladesh 710
IE - Irlanda 592
NL - Olanda 579
KR - Corea 531
MX - Messico 502
CA - Canada 477
UA - Ucraina 461
ID - Indonesia 432
FI - Finlandia 412
AR - Argentina 321
CO - Colombia 299
PL - Polonia 273
BE - Belgio 236
PH - Filippine 217
TH - Thailandia 213
AU - Australia 208
PT - Portogallo 200
EU - Europa 199
GR - Grecia 191
TW - Taiwan 164
EG - Egitto 161
AT - Austria 152
CL - Cile 147
RO - Romania 145
CH - Svizzera 137
CI - Costa d'Avorio 137
DK - Danimarca 123
SA - Arabia Saudita 103
PK - Pakistan 94
PE - Perù 88
IR - Iran 85
IQ - Iraq 78
EC - Ecuador 77
ZA - Sudafrica 76
VE - Venezuela 75
IL - Israele 67
MA - Marocco 64
MY - Malesia 52
CZ - Repubblica Ceca 51
JO - Giordania 51
UY - Uruguay 46
HU - Ungheria 44
AE - Emirati Arabi Uniti 42
GT - Guatemala 34
KE - Kenya 34
CR - Costa Rica 32
LB - Libano 32
NZ - Nuova Zelanda 32
TN - Tunisia 32
UZ - Uzbekistan 32
NO - Norvegia 30
BG - Bulgaria 29
DZ - Algeria 28
SK - Slovacchia (Repubblica Slovacca) 28
NI - Nicaragua 24
PY - Paraguay 24
LT - Lituania 22
NP - Nepal 22
RS - Serbia 22
DO - Repubblica Dominicana 21
HR - Croazia 21
ET - Etiopia 20
JM - Giamaica 19
SI - Slovenia 19
AL - Albania 18
LU - Lussemburgo 17
GE - Georgia 16
KZ - Kazakistan 16
PA - Panama 16
HN - Honduras 15
CY - Cipro 14
BO - Bolivia 13
AZ - Azerbaigian 12
LV - Lettonia 11
LY - Libia 11
NG - Nigeria 11
EE - Estonia 10
PR - Porto Rico 10
QA - Qatar 10
BH - Bahrain 9
MD - Moldavia 9
OM - Oman 9
BA - Bosnia-Erzegovina 8
KH - Cambogia 8
Totale 70.419
Città #
Frankfurt am Main 8.750
Southend 3.020
Singapore 2.913
Ashburn 1.921
Chandler 1.506
Hong Kong 1.389
San Jose 1.154
Milan 1.015
Beijing 888
Dallas 780
Princeton 682
Council Bluffs 565
Dublin 561
Seattle 555
Wilmington 492
Fairfield 438
Los Angeles 414
New York 402
Rome 400
Bengaluru 375
Ho Chi Minh City 363
Guangzhou 358
Lauterbourg 328
Nanjing 326
Jacksonville 323
Hanoi 319
Redwood City 302
São Paulo 297
Dearborn 293
Shanghai 291
Santa Clara 289
Hefei 269
Tokyo 269
Des Moines 250
Moscow 244
Buffalo 242
Toronto 242
Houston 237
Redmond 235
Woodbridge 233
Istanbul 227
Cambridge 206
Bogotá 185
Mountain View 184
Helsinki 179
Jakarta 171
Ann Arbor 170
Columbus 157
Madrid 154
Jinan 148
Shenyang 144
The Dalles 141
Boardman 140
Munich 140
Abidjan 137
Grafing 131
Sakarya 128
Chicago 124
Bangkok 123
Seoul 119
Buenos Aires 116
Barcelona 110
Phoenix 109
Hangzhou 107
Nanchang 107
Tianjin 105
Naples 104
Berlin 102
Andover 100
Athens 99
Cangzhou 99
Rio de Janeiro 93
Shenzhen 91
Valencia 89
Serra 88
Nuremberg 87
Santiago 86
Warsaw 86
Paris 83
London 82
Turin 81
Brussels 80
Bologna 76
Mexico City 76
Cairo 74
Dong Ket 74
Vienna 73
Hebei 71
Taipei 70
Changsha 69
Chengdu 69
Somerville 69
Lima 68
Ankara 65
Wuhan 65
Florence 64
San Diego 64
Palermo 63
Chennai 62
Zhengzhou 62
Totale 40.376
Nome #
A randomized trial of robotic mastectomy versus open surgery in women with breast cancer or BRCA mutation 4.278
Axillary surgery in breast cancer : an updated historical perspective 3.692
Risk and incidence of breast cancer in transgender individuals: a systematic review and meta-analysis 2.534
Standard and controversies in sentinel node in breast cancer patients 2.102
Breast phyllodes tumor : A review of literature and a single center retrospective series analysis 1.290
Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes 1.073
LINFOADENECTOMIA LATEROCERVICALE PER METASTASI LINFONODALI DA MELANOMA MALIGNO. TECNICA CHIRURGICA 793
Sentinel lymph node biopsy and axillary dissection in breast cancer: Results in a large series 617
Sentinel lymph node biopsy in microinvasive ductal carcinoma in situ 477
Mondor's disease and breast cancer 444
Effect of raloxifene on breast cancer cell Ki67 and apoptosis: a double-blind, placebo-controlled, randomized clinical trial in postmenopausal patients 433
Outcomes of patients with breast cancer who present with ipsilateral supraclavicular or internal mammary lymph node metastases 397
Efficacy of Alternative Dose Regimens of Exemestane in Postmenopausal Women With Stage 0 to II Estrogen Receptor-Positive Breast Cancer: A Randomized Clinical Trial 382
Changes in surgicaL behaviOrs dUring the CoviD-19 pandemic : the SICE CLOUD19 Study 374
A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers 342
Identification and clinical validation of a multigene assay that interrogates the biology of cancer stem cells and predicts metastasis in breast cancer : a retrospective consecutive study 326
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial 325
Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment 318
Update on the Feasibility and Progress on Robotic Breast Surgery 316
ANGIOSARCOMA DELLA MAMMELLA.DESCRIZIONE DI UN CASO CLINICO E REVISIONE DELLA LETTERATURA 314
CDK12 promotes tumorigenesis but induces vulnerability to therapies inhibiting folate one- carbon metabolism in breast cancer 310
Pegylated liposomal doxorubicin (Caelyx®) as adjuvant treatment in early-stage luminal b-like breast cancer : A feasibility phase II trial 310
Preliminary report of robotic nipple-sparing mastectomy and immediate breast reconstruction with implant 308
Pegylated liposomal doxorubicin in combination with low-dose metronomic cyclophosphamide as preoperative treatment for patients with locally advanced breast cancer 295
Breast cancer with rare metastatic manifestation 288
E-cadherin deregulation in breast cancer 285
Preventing chemotherapy-induced alopecia : a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines 275
The prolonged clinical benefit with metronomic chemotherapy (VEX regimen) in metastatic breast cancer patients 269
De-escalation treatment of axilla in breast cancer 267
Comparison of StemPrintER with Oncotype DX Recurrence Score for predicting risk of breast cancer distant recurrence after endocrine therapy 262
Aiuto medico a morire e diritto: per la costruzione di un dibattito pubblico, plurale e consapevole : documento di sintesi del gruppo di lavoro in materia di aiuto medico al morire 260
Is periodontitis a risk indicator for cancer? A meta-analysis 258
Angiosarcoma and atypical vascular lesions of the breast : diagnostic and prognostic role of MYC gene amplification and protein expression 257
Oncoplastic Breast-Conserving Surgery for Synchronous Multicentric and Multifocal Tumors: Is It Oncologically Safe? A Retrospective Matched-Cohort Analysis 257
Intra- and inter-observer variability in breast tumour bed contouring and the controversial role of surgical clips 255
High-dose-rate Brachytherapy as Adjuvant Local rEirradiation for Salvage Treatment of Recurrent breAst cancer (BALESTRA): a retrospective mono-institutional study 255
Ductal carcinoma in situ and intraoperative partial breast irradiation: Who are the best candidates? Long-term outcome of a single institution series 253
Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy 250
Do clinicopathological features of the cancer patient relate with nipple areolar complex necrosis in nipple-sparing mastectomy? 242
Validation of a Novel Nomogram for Prediction of Local Relapse after Surgery for Invasive Breast Carcinoma 241
Comparing TomoHelical and TomoDirect in postmastectomy hypofractionated radiotherapy after immediate breast reconstruction 240
Metaplastic breast cancer: an all-round multidisciplinary consensus 239
Diagnostic performance of image-guided vacuum-assisted breast biopsy after neoadjuvant therapy for breast cancer: prospective pilot study 239
Breast cancer subtypes and outcome after local and regional relapse 239
HALFMOON TomoTherapy (Helical ALtered Fractionation for iMplant partial OmissiON): implant-sparing post-mastectomy radiotherapy reshaping the clinical target volume in the reconstructed breast 239
The Effect of Adjuvant Radiotherapy on One- and Two-Stage Prosthetic Breast Reconstruction and on Autologous Reconstruction: A Multicenter Italian Study among 18 Senonetwork Breast Centres 234
E-cadherin germline mutations in Māori population 232
Breast Adjuvant Radiotherapy Amid the COVID-19 Crisis in a Hub Cancer Center, Lombardy, Italy 232
Towards mm-wave spectroscopy for dielectric characterization of breast surgical margins 229
Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features 228
A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancer 226
Evaluation of fat grafting safety in patients with intra epithelial neoplasia: a matched-cohort study 223
Phase II trial of combination of pegylated liposomal doxorubicin, cisplatin, and infusional 5-fluorouracil (CCF) plus trastuzumab as preoperative treatment for locally advanced and inflammatory breast cancer 218
Breast cancer : from maximum tolerable to minimum effective treatment 216
Early Breast Cancers During Pregnancy Treated With Breast-Conserving Surgery in the First Trimester of Gestation: A Feasibility Study 215
Giant malignant phyllodes tumor of the breast: Insights into optimal management and reconstructive options for a rare and challenging entity 214
Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion 214
Hypofractionated proton therapy in breast cancer: where are we? A critical review of the literature 214
Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study 211
Long-Term Results and Reconstruction Failure in Patients Receiving Postmastectomy Radiation Therapy with a Temporary Expander or Permanent Implant in Place 210
Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial 210
Ductal Carcinoma In Situ (DCIS) and Microinvasive DCIS: Role of Surgery in Early Diagnosis of Breast Cancer 209
Breast-conserving surgery in BRCA1/2 mutation carriers: are we approaching an answer? 208
Acute and intermediate toxicity of 3-week radiotherapy with simultaneous integrated boost using TomoDirect: prospective series of 287 early breast cancer patients 208
Neoadjuvant pegylated liposomal doxorubicin in combination with cisplatin and infusional fluoruracil (CCF) with and without endocrine therapy in locally advanced primary or recurrent breast cancer 207
Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial 207
Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expression 207
BIA-ALCL in patients with genetic predisposition for breast cancer: our experience and a review of the literature 206
Ultra-hypofractionated whole breast adjuvant radiotherapy in the real-world setting: single experience with 271 elderly/frail patients treated with 3D and IMRT technique 206
CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype 204
Oncoplastic Breast-Conserving Surgery for Tumors Larger than 2 Centimeters : Is it Oncologically Safe? A Matched-Cohort Analysis 204
Avoiding axillary dissection in breast cancer surgery : a randomized trial to assess the role of axillary radiotherapy 202
Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features 202
This house believes that: Sentinel node biopsy alone is better than TAD after NACT for cN+ patients 201
Prognostic relevance of peritumoral vascular invasion in immunohistochemically defined subtypes of node-positive breast cancer 201
A new option for early breast cancer patients previously irradiated for Hodgkin's disease: intraoperative radiotherapy with electrons (ELIOT) 200
Surgical treatment of breast lesions at a Day Centre : Experience of the European Institute of Oncology 200
Erratum to: Current Trends in the Oncologic and Surgical Managements of Breast Cancer in Women with Implants: Incidence, Diagnosis, and Treatment 199
Evaluation of endocrine therapy and patients preferences in early breast cancer: results of Elena study 199
CDH1 germline mutations in healthy individuals from families with the hereditary diffuse gastric cancer syndrome 199
Ductal carcinoma in situ of the male breast: clinical radiological features and management in a cancer referral center 197
A narrative review for radiation oncologists to implement preoperative partial breast irradiation 196
Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trials 194
Oncological Outcomes of Nipple-Sparing Mastectomy : a Single-Center Experience of 1989 Patients 193
Local Failure After Accelerated Partial Breast Irradiation with Intraoperative Radiotherapy with Electrons : An Insight into Management and Outcome from an Italian Multicentric Study 193
Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatment 192
Influence of margin status on outcomes in lobular carcinoma: experience of the European Institute of Oncology 192
Geographical distribution of e‐cadherin germline mutations in the context of diffuse gastric cancer : A systematic review 192
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01) : a phase 3 randomised controlled trial 191
The POLO (Partially Omitted Lobe) approach to safely treat in-breast recurrence after intraoperative radiotherapy with electrons 191
Breast Cancer during Pregnancy as a Special Type of Early-Onset Breast Cancer: Analysis of the Tumor Immune Microenvironment and Risk Profiles 190
Surgical Management of Inherited Breast Cancer: Role of Breast-Conserving Surgery 190
Prognostic impact of germline BRCA1/2 pathogenic variants in breast cancer 190
A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer 190
Germline CDH1 variants in hereditary diffuse gastric cancer syndrome with focus on younger women 189
Antitumour and biological effects of letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancer 188
Feasibility and surgical impact of Z0011 trial criteria in a single-Institution practice 187
Hypofractionated postmastectomy radiotherapy with helical tomotherapy in patients with immediate breast reconstruction : dosimetric results and acute/intermediate toxicity evaluation 185
The indocyanine green method is equivalent to the 99mTc-labeled radiotracer method for identifying the sentinel node in breast cancer : a concordance and validation study 185
Integrated analysis of mismatch repair, PD-L1, and immune microenvironment status in pregnancy-associated breast cancers 185
Totale 38.625
Categoria #
all - tutte 166.552
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 166.552


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.213 0 0 0 0 0 0 0 0 0 0 780 433
2021/20225.081 293 260 246 292 364 332 513 336 579 393 363 1.110
2022/20236.846 699 531 497 692 700 1.028 294 549 600 332 501 423
2023/202412.582 385 581 502 614 971 573 1.723 1.717 759 1.405 1.713 1.639
2024/202513.183 1.465 1.576 1.276 1.362 855 503 465 1.145 704 920 1.064 1.848
2025/202618.929 1.855 1.281 2.126 1.577 1.892 1.218 2.424 1.078 2.071 1.425 1.982 0
Totale 73.096